H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready For Testing To Prevent Possible Pandemic
LONDON, April 9, 2013 /PRNewswire/ -- Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died from the virus.
The new vaccine is produced without any biological substances and will be used without adjuvants, similar to the H5N1 Synthetic Replikins Vaccine which was found effective (1).
Contact: Email tel 646-320-5910
References1. Jackwood et al. Avian Diseases 53(4): 613‐617, 20092. <Replikins.com>This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com. SOURCE Replikins Ltd
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts